Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 726.27

+4.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (702)	11/2/2002 8:08:58 AM
From: Biotech Jim	Read Replies (1) of 3559

Miljenko- Do you know the overall size of morbidly obese pts in the US (ie, BMI>40). I seem to get a diverse picture from bariatric surgery centers. Also, do you know that genotyping is allowed in this study? You are absolutely right when you say "Severe and morbid obesity is lifetime disease and extended data will be as important as first 12 months." I am getting more interested in REGN now myself. If you buy REGN now for the axokine project, you get the cytokine traps as the bonus.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next